Compare PCRX & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | PRCH |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2010 | 2019 |
| Metric | PCRX | PRCH |
|---|---|---|
| Price | $22.77 | $9.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $30.25 | $18.63 |
| AVG Volume (30 Days) | 515.7K | ★ 2.2M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | 90.91 |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $541,533,000.00 | $482,414,000.00 |
| Revenue This Year | $6.78 | $4.15 |
| Revenue Next Year | $8.54 | $17.05 |
| P/E Ratio | $336.79 | ★ N/A |
| Revenue Growth | ★ 26.04 | 10.18 |
| 52 Week Low | $18.80 | $6.36 |
| 52 Week High | $27.64 | $19.44 |
| Indicator | PCRX | PRCH |
|---|---|---|
| Relative Strength Index (RSI) | 41.55 | 55.90 |
| Support Level | $22.13 | $8.93 |
| Resistance Level | $24.20 | $11.19 |
| Average True Range (ATR) | 1.26 | 0.73 |
| MACD | -0.25 | -0.05 |
| Stochastic Oscillator | 8.81 | 54.02 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.